PKP2缺失小鼠右心室钙稳态与连接蛋白43半通道功能紊乱早于明显致心律失常性心肌病
该研究在心肌细胞特异性他莫昔芬诱导PKP2敲除小鼠(PKP2cKO)中,于他莫昔芬注射后14天(明显电学或结构表型出现前)分别研究左右心室游离壁心肌细胞。结果显示PKP2cKO左心室心肌细胞多数特性与对照无差异,而右心室心肌细胞出现钙瞬变幅度和时程增加、胞质和肌浆网钙增加、自发性钙释放事件(火花)频率增加、线粒体钙动态蓄积,以及早期和延迟后瞬变和Langendorff灌注心脏心律失常易感性增高。结论认为PKP2缺失产生右心室为主的致心律失常基质(钙调节紊乱),早于心肌病,部分由连接蛋白43依赖性膜通道介导并可被蛋白激酶C抑制剂抑制。
要点
- PKP2cKO小鼠右心室心肌细胞在结构/电学表型出现前已表现出钙瞬变幅度和时程增加及钙火花频率增加。
- 右心室心肌细胞显示早期和延迟后瞬变,Langendorff灌注心脏心律失常易感性增高。
- 连接蛋白43敲除减轻膜通透性增加、胞质钙蓄积和火花频率增加;GAP19阻断半通道或PKC抑制可改善钙稳态。
核心结论
- PKP2缺失产生右心室为主的钙调节紊乱致心律失常基质,早于心肌病出现,至少部分由连接蛋白43依赖性膜通道介导并可被蛋白激酶C抑制剂抑制。
研究设计与样本
- 使用心肌细胞特异性、他莫昔芬激活的PKP2敲除小鼠(PKP2cKO),于他莫昔芬注射后14天(明显电学或结构表型出现前)进行研究。
- 采用多种成像、生化及高分辨率质谱方法,分别研究右心室或左心室游离壁来源的细胞/组织。
主要发现
- PKP2cKO左心室心肌细胞多数特性与对照无差异。
- PKP2cKO右心室心肌细胞钙瞬变幅度和时程增加,胞质和肌浆网钙增加,自发性钙释放事件(火花)频率增加(即使在相当肌浆网负荷下),线粒体钙动态蓄积。
- 右心室心肌细胞出现早期和延迟后瞬变,Langendorff灌注心脏心律失常易感性增高。
- PKP2cKO右心室细胞中兰尼碱受体2钙敏感性增强,并在已知调节钙门控的结构域优先磷酸化。
- 他莫昔芬注射后14天RNAseq显示右心室与左心室之间转录本丰度无相关差异(对照和PKP2cKO细胞均如此);右心室为主的膜通透性增加可允许钙进入细胞。
临床怎么用
- 在PKP2相关致心律失常性右心室心肌病中,右心室钙调节紊乱可能早于结构改变,提示钙处理异常或可作为早期干预靶点。
- 连接蛋白43半通道阻断(如GAP19)或蛋白激酶C抑制在实验模型中可改善钙稳态和火花频率,但尚未转化为临床推荐。
局限性
- 研究为小鼠模型,结果不能直接外推至人类。
- 研究聚焦于他莫昔芬注射后14天一个时间点,未描述更早或更晚时间点的动态变化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Plakophilin-2 (PKP2) is classically defined as a desmosomal protein. Mutations in PKP2 associate with most cases of gene-positive arrhythmogenic right ventricular cardiomyopathy. A better understanding of PKP2 cardiac biology can help elucidate the mechanisms underlying arrhythmic and cardiomyopathic events consequent to PKP2 deficiency. Here, we sought to capture early molecular/cellular events that can act as nascent arrhythmic/cardiomyopathic substrates. METHODS: We used multiple imaging, biochemical and high-resolution mass spectrometry methods to study functional/structural properties of cells/tissues derived from cardiomyocyte-specific, tamoxifen-activated, PKP2 knockout mice (PKP2cKO) 14 days post-tamoxifen injection, a time point preceding overt electrical or structural phenotypes. Myocytes from right or left ventricular free wall were studied separately. RESULTS: Most properties of PKP2cKO left ventricular myocytes were not different from control; in contrast, PKP2cKO right ventricular (RV) myocytes showed increased amplitude and duration of Ca2+ transients, increased Ca2+ in the cytoplasm and sarcoplasmic reticulum, increased frequency of spontaneous Ca2+ release events (sparks) even at comparable sarcoplasmic reticulum load, and dynamic Ca2+ accumulation in mitochondria. We also observed early- and delayed-after transients in RV myocytes and heightened susceptibility to arrhythmias in Langendorff-perfused hearts. In addition, ryanodine receptor 2 in PKP2cKO-RV cells presented enhanced Ca2+ sensitivity and preferential phosphorylation in a domain known to modulate Ca2+ gating. RNAseq at 14 days post-tamoxifen showed no relevant difference in transcript abundance between RV and left ventricle, neither in control nor in PKP2cKO cells. Instead, we found an RV-predominant increase in membrane permeability that can permit Ca2+ entry into the cell. Connexin 43 ablation mitigated the membrane permeability increase, accumulation of cytoplasmic Ca2+, increased frequency of sparks and early stages of RV dysfunction. Connexin 43 hemichannel block with GAP19 normalized [Ca2+]i homeostasis. Similarly, protein kinase C inhibition normalized spark frequency at comparable sarcoplasmic reticulum load levels. CONCLUSIONS: Loss of PKP2 creates an RV-predominant arrhythmogenic substrate (Ca2+ dysregulation) that precedes the cardiomyopathy; this is, at least in part, mediated by a Connexin 43-dependent membrane conduit and repressed by protein kinase C inhibitors. Given that asymmetric Ca2+ dysregulation precedes the cardiomyopathic stage, we speculate that abnormal Ca2+ handling in RV myocytes can be a trigger for gross structural changes observed at a later stage.
引用
- Kim JC, Pérez-Hernández M, Alvarado FJ, et al. Disruption of Ca2+i Homeostasis and Connexin 43 Hemichannel Function in the Right Ventricle Precedes Overt Arrhythmogenic Cardiomyopathy in Plakophilin-2-Deficient Mice. Circulation. 2019. PMID: 31315456. doi:10.1161/CIRCULATIONAHA.119.039710
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。